Table 1.
Sensitivity and specificity of recent cardiovascular magnetic resonance perfusion studies on a per-patient basis for detecting coronary arterial luminal narrowings greater than 50%
| Investigators | n | Stress agent | Sensitivity,% | Specificity,% |
|---|---|---|---|---|
| Burgstahler et al. | 23 | Adenosine | 100 | 83 |
| Cheng et al. | 61 | Adenosine | 90 | 67 |
| Cury et al. | 46 | Dipyridamole | 97 | 75 |
| Doyle et al. | 184 | Dipyridamole | 57 | 78 |
| Gebker et al. | 101 | Adenosine | 90 | 71 |
| Greenwood et al. | 35 | Adenosine | 72 | 100 |
| Giang et al. | 44 | Adenosine | 93 | 75 |
| Ishida et al. | 104 | Dipyridamole/exercise | 90 | 85 |
| Kawase et al. | 50 | Nicorandil | 94 | 94 |
| Klein et al. | 54 | Adenosine | 87 | 88 |
| Klem et al. | 92 | Adenosine | 89 | 87 |
| Klem et al. | 147 | Adenosine | 84 | 88 |
| Merkle et al. | 228 | Adenosine | 96 | 72 |
| Meyer et al. | 60 | Adenosine | 89 | 79 |
| Nagel et al. | 84 | Adenosine | 88 | 90 |
| Paetsch et al. | 79 | Adenosine/dobutamine | 91 | 62 |
| Pilz et al. | 171 | Adenosine | 96 | 83 |
| Pilz et al. | 218 | Adenosine | 92 | 100 |
| Plein et al. | 82 | Adenosine | 88 | 74 |
| Seeger et al. | 51 | Adenosine | 92 | 85 |
| Sakuma et al. | 40 | Dipyridamole | 81 | 68 |
| Schwitter et al. | 47 | Dipyridamole | 86 | 70 |
| Takase et al. | 102 | Dipyridamole | 93 | 85 |
| Thiele et al. | 32 | Adenosine | 75 | 97 |
| Thomas et al. | 60 | Adenosine | 93 | 84 |
Data from Hamon et al. [33•]